Amniotic membrane in the treatment of neuroparalytic keratopathy (CROSBI ID 139811)
Prilog u časopisu | izvorni znanstveni rad
Podaci o odgovornosti
Bednar, Ivana ; Iveković, Renata ; Petric, Ivanka ; Novak-Lauš Katia ; Mandić, Zdravko
engleski
Amniotic membrane in the treatment of neuroparalytic keratopathy
The aim of the study was to determine whether amniotic membrane could be used to treat neuroparalytic keratopathy. Amniotic membrane transplantation was performed in 19 patients with neuroparalytic ulcer. All patients were younger than 61 and all developed corneal problems due to interruption of the sensory afferent fiber innervating the cornea. In all patients, the follow up period was longer than 18 months. Postoperatively, the pain was reduced in study patients. In one patient, retransplantation for disease recurrence was performed two months after the first operation. After the second operation, the pain was minimized for more than 18 months. Amniotic membrane transplantation appears to be a good method for pain reduction and better epithelial healing in patients with neuroparalytic keratopathy.
amniotic membrane; neuroparalytic keratopathy
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano